Literature DB >> 15494120

Severity dependent up-regulations of LOX-1 and MCP-1 in early sclerotic changes of common carotid arteries in spontaneously hypertensive rats.

Y Hamakawa1, N Omori, M Ouchida, M Nagase, K Sato, I Nagano, M Shoji, T Fujita, K Abe.   

Abstract

Lectin-like oxidized low-density lipoprotein receptor (LOX-1) and monocyte chemoattractant protein-1 (MCP-1) are molecules involving in the initiation and progression of atherosclerosis. In order to examine a possible difference in LOX-1 and MCP-1 expressions depending on the severity of early stage of atherosclerosis, we investigated atherosclerotic changes by exposure to hypertension and hyperlipidemia in common carotid arteries (CCAs) of stroke-prone spontaneously hypertensive rat (SHR-SP). Three rat model groups such as control [Wistar Kyoto rat (WKY) group], hypertension (SHR-SP group) and hypertension + hyperlipidemia [SHR-SP + high fat and cholesterol (HFC) group] were used. Body weights, brain weights, systolic blood pressures and serum levels of total cholesterol, low-density lipoprotein and triglyceride were measured at 0, 5, 10 and 15 days after appropriate diet. Immunohistochemistry showed that the positive area and the strength of LOX-1 and MCP-1 were larger in the SHR-SP + HFC group than in the SHR-SP group, while no immunoreactivities were found in the WKY group. Conventional RT-PCR and real-time PCR analyses showed that mRNAs of those in the SHR-SP group were higher with greater up-regulation in the SHR-SP + HFC group. LOX-1 and MCP-1 expressions were coordinately up-regulated at mRNA and protein levels in an early stage of sclerosis depending on the severity of atherosclerotic stress. Activations of LOX-1 and MCP-1 are collectively involved in the early stage of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494120     DOI: 10.1179/016164104225016074

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  6 in total

Review 1.  Vascular Endothelial Cells and Innate Immunity.

Authors:  Ying Shao; Jason Saredy; William Y Yang; Yu Sun; Yifan Lu; Fatma Saaoud; Charles Drummer; Candice Johnson; Keman Xu; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-27       Impact factor: 8.311

Review 2.  The discovery of LOX-1, its ligands and clinical significance.

Authors:  Ryo Yoshimoto; Yoshiko Fujita; Akemi Kakino; Shin Iwamoto; Tomohide Takaya; Tatsuya Sawamura
Journal:  Cardiovasc Drugs Ther       Date:  2011-10       Impact factor: 3.727

3.  Effect of oral magnesium sulfate administration on lectin-like oxidized low-density lipoprotein receptor-1 gene expression to prevent atherosclerosis in diabetic rat vessels.

Authors:  Mina Fazlali; Fatemeh Kharazmi; Mitra Kamran; Kianoosh Malekzadeh; Ardeshir Talebi; Fatemeh Khosravi; Nepton Soltani
Journal:  J Diabetes Investig       Date:  2018-12-04       Impact factor: 4.232

4.  Detection of a High Ratio of Soluble to Membrane-Bound LOX-1 in Aspirated Coronary Thrombi From Patients With ST-Segment-Elevation Myocardial Infarction.

Authors:  An-Sheng Lee; Yu-Chen Wang; Shih-Sheng Chang; Ping-Hang Lo; Chia-Ming Chang; Jonathan Lu; Alan R Burns; Chu-Huang Chen; Akemi Kakino; Tatsuya Sawamura; Kuan-Cheng Chang
Journal:  J Am Heart Assoc       Date:  2020-01-13       Impact factor: 5.501

Review 5.  An evolving new paradigm: endothelial cells--conditional innate immune cells.

Authors:  Jietang Mai; Anthony Virtue; Jerry Shen; Hong Wang; Xiao-Feng Yang
Journal:  J Hematol Oncol       Date:  2013-08-22       Impact factor: 17.388

6.  Cerebrovascular gene expression in spontaneously hypertensive rats.

Authors:  Anne-Sofie Grell; Simona Denise Frederiksen; Lars Edvinsson; Saema Ansar
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.